Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-06-17

Clinical Trial Update: Immunopharmacological Effects of Rituximab in Atopic Dermatitis [NA]

View source ↗

Summary

A completed clinical trial update evaluating the immunopharmacological effects of Rituximab in patients with atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (rituximab)

Snippet

Sponsor: University of Bern | Conditions: Dermatitis, Atopic | NA | Status: COMPLETED